MECHANISM OF IMMUNE INTERFERON SYNTHESIS IN THYMOCYTES
胸腺细胞中免疫干扰素合成机制
基本信息
- 批准号:3171463
- 负责人:
- 金额:$ 12.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-08-01 至 1987-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This research has as its goal the study of the mechanism of induction of
gamma interferon synthesis by human thymocytes in vitro. It is based on
our original observation that human thymocytes can be induced to synthesize
interferon by two agents: a lectin and products of B-lymphoblastoid cell
lines.
This is the first observation of induction of gamma interferon, a
lymphokine, by precursors of T lymphocytes. It is our aim to identify the
thymocyte subsets that are induced and to correlate the induction of
interferon synthesis with the acquisition of other immune functions
characteristic of mature T lymphocytes. T lymphocytes play a crucial role
in cellular immune defense, and the recruitment of thymocytes in immune
defense against pathogens or tumor cells may be of vital importance. In
view of the response of thymocytes to stimuli that cause gamma interferon
synthesis, we also plan to investigate whether thymocytes acquire other
immune functions characteristic of mature T lymphocytes when interferon
synthesis is induced. It is our goal to investigate the immunoregulatory
functions of gamma interferon, in particular its effect on T-cell-dependent
immunoglobulin synthesis by thymocytes.
Furthermore, we continue our investigation of the relationship between
interleukin-2 and gamma interferon synthesis and the pharmacologic
regulation of gamma IFN synthesis.
The mechanism of induction of gamma interferon is of crucial importance for
the understanding of one of the factors that influence host response to
invasion by tumor cells in lines. (IS)
本研究的目的是研究诱导的机制,
人胸腺细胞体外合成γ干扰素。 它是基于
我们最初观察到人类胸腺细胞可以被诱导合成
两种干扰素:凝集素和B淋巴母细胞产物
线
这是第一次观察到γ干扰素的诱导,
淋巴因子,通过T淋巴细胞的前体。 我们的目标是确定
诱导的胸腺细胞亚群,
干扰素合成与其他免疫功能的获得
成熟T淋巴细胞的特征。 T淋巴细胞起着关键作用
在细胞免疫防御中,胸腺细胞在免疫防御中的募集
对病原体或肿瘤细胞的防御可能是至关重要的。 在
胸腺细胞对引起γ干扰素的刺激的反应的看法
合成,我们还计划研究胸腺细胞是否获得其他
当干扰素作用时,成熟T淋巴细胞免疫功能特征
合成是诱导的。 我们的目标是研究免疫调节
γ干扰素的功能,特别是其对T细胞依赖性
胸腺细胞合成免疫球蛋白。
此外,我们继续调查
白细胞介素-2和γ干扰素的合成及其药理学
γ IFN合成的调节。
γ-干扰素的诱导机制对于
了解影响宿主对病毒反应的因素之一,
肿瘤细胞呈直线侵入。 (IS)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GABRIELLE H REEM其他文献
GABRIELLE H REEM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GABRIELLE H REEM', 18)}}的其他基金
CYCLOSPORINE AND GENE EXPRESSION BY HUMAN THYMOCYTES
环孢菌素和人类胸腺细胞的基因表达
- 批准号:
3140227 - 财政年份:1988
- 资助金额:
$ 12.37万 - 项目类别:
CYCLOSPORINE AND GENE EXPRESSION BY HUMAN THYMOCYTES
环孢菌素和人类胸腺细胞的基因表达
- 批准号:
3140230 - 财政年份:1988
- 资助金额:
$ 12.37万 - 项目类别:
CYCLOSPORINE AND GENE EXPRESSION BY HUMAN THYMOCYTES
环孢菌素和人类胸腺细胞的基因表达
- 批准号:
3140229 - 财政年份:1988
- 资助金额:
$ 12.37万 - 项目类别:
CYCLOSPORINE AND GENE EXPRESSION BY HUMAN THYMOCYTES
环孢菌素和人类胸腺细胞的基因表达
- 批准号:
3140225 - 财政年份:1988
- 资助金额:
$ 12.37万 - 项目类别:
CYCLOSPORINE AND GENE EXPRESSION BY HUMAN THYMOCYTES
环孢菌素和人类胸腺细胞的基因表达
- 批准号:
3140228 - 财政年份:1988
- 资助金额:
$ 12.37万 - 项目类别:
MECHANISM OF IMMUNE INTERFERON SYNTHESIS IN THYMOCYTES
胸腺细胞中免疫干扰素合成机制
- 批准号:
3171464 - 财政年份:1983
- 资助金额:
$ 12.37万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 12.37万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 12.37万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 12.37万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 12.37万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 12.37万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 12.37万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 12.37万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 12.37万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 12.37万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 12.37万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




